Professional
Added to YB: 2025-07-14
Pitch date: 2025-07-11
MDT [bullish]
Medtronic plc
+10.67%
current return
Author Info
No bio for this author
Company Info
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
Market Cap
$120.0B
Pitch Price
$86.25
Price Target
99.00 (+4%)
Dividend
3.07%
EV/EBITDA
13.05
P/E
23.11
EV/Sales
3.72
Sector
Health Care Equipment and Supplies
Category
special_situation
Citi Reiterates Buy Rating on $MDT, PT $99
MDT: Citi opens 90-day upside catalyst watch, reiterates Buy/$99 PT. Favorable CMS draft coverage for renal denervation matches FDA label. Upcoming catalysts: final RDN coverage Oct 8, Hugo robot FDA approval for urology, Minimed 780G label expansions for Type 2 diabetes + Abbott Libre CGM integration.
Read full article (1 min)